Literature DB >> 1520765

Superantigens, T cells, and microbes.

A Zumla1.   

Abstract

It is well recognized that toxins of Staphylococcus aureus and Streptococcus pyogenes are responsible for a wide range of clinical conditions, although their precise mode of action remains unclear. Recently, there has been a resurgence of interest in these toxins, now grouped with superantigens, because they cause profound alterations in the immune system homeostasis. Superantigens are molecules, including endogenous retroviral gene products and microbial toxins, that share a unique set of characteristics. They bind with high affinity to major histocompatibility complex class II at regions distinct from the conventional antigen binding groove and cause prolific activation or anergy of T cells with certain T cell receptor variable-region gene families. Whilst most of the superantigens described to date are products of bacteria or viruses, the presence of superantigens in parasites and their role in disease pathogenesis remain to be defined. It is probable that associations are present between superantigen-induced proliferation or anergy of peripheral blood T cells and clinical manifestations of human infectious diseases. The identification of these may pave the way toward a better understanding of disease pathogenesis and the possible development of newer immunotherapeutic regimes. This review summarizes the current thinking on microbial superantigens, their association with human T cells, and speculations about their significance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1520765     DOI: 10.1093/clinids/15.2.313

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  10 in total

Review 1.  Bacterial pyrogenic exotoxins as superantigens.

Authors:  M Kotb
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

2.  Opportunistic infections and CD4+ T-lymphocytopenia without HIV infection: report of two cases.

Authors:  R G Lalonde; P René; M A Wainberg
Journal:  CMAJ       Date:  1993-07-15       Impact factor: 8.262

3.  Staphylococcal enterotoxin B-induced acute inflammation is inhibited by dexamethasone: important role of CXC chemokines KC and macrophage inflammatory protein 2.

Authors:  Rene Schramm; Henrik Thorlacius
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

4.  Selective expansion of T cells in gingival lesions of patients with chronic inflammatory periodontal disease.

Authors:  K Yamazaki; T Nakajima; Y Ohsawa; K Tabeta; H Yoshie; K Sakurai; G J Seymour
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

Review 5.  Predictors of mortality in Staphylococcus aureus Bacteremia.

Authors:  Sebastian J van Hal; Slade O Jensen; Vikram L Vaska; Björn A Espedido; David L Paterson; Iain B Gosbell
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

6.  IL-4 down-regulates IL-2-, IL-3-, and GM-CSF-induced cytokine gene expression in peripheral blood monocytes.

Authors:  F H Cluitmans; B H Esendam; J E Landegent; R Willemze; J H Falkenburg
Journal:  Ann Hematol       Date:  1994-06       Impact factor: 3.673

7.  Response to superantigen stimulation in peripheral blood mononuclear cells from children perinatally infected with human immunodeficiency virus and receiving highly active antiretroviral therapy.

Authors:  Thomas W McCloskey; Viraga Haridas; Lucy Pontrelli; Savita Pahwa
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

Review 8.  Selective targeting of the immune response in autoimmune demyelination.

Authors:  J R Oksenberg
Journal:  West J Med       Date:  1994-09

9.  T cell receptor V beta gene bias in rheumatoid arthritis.

Authors:  R N Jenkins; A Nikaein; A Zimmermann; K Meek; P E Lipsky
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

Review 10.  Methicillin-resistant Staphylococcus aureus bacteremia among liver transplant recipients: epidemiology and associated risk factors for morbidity and mortality.

Authors:  Taohua Liu; Yuezhong Zhang; Qiquan Wan
Journal:  Infect Drug Resist       Date:  2018-05-03       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.